This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Nature Reviews Cardiology, Published online: 07 February 2025; doi:10.1038/s41569-025-01131-4 Hypertension is the leading cause of death globally but has low rates of diagnosis and treatment.
Akshay Desai, MD “Compared to placebo, a single injection of zilebesiran resulted in clinically meaningful reductions in bloodpressure at three months when added to commonly used antihypertensive treatments,” said Akshay Desai, MD, MPH , a cardiologist at Brigham and Women’s Hospital in Boston and a study coauthor. “In
Hypertension, Ahead of Print. Hypertension is a leading risk factor for cardiovascular morbidity and mortality. Despite the widespread availability of both pharmacological and lifestyle therapeutic options, bloodpressure control rates across the globe are worsening.
Hypertension, Ahead of Print. Although orthostatic hypotension (OH) has long been recognized as a manifestation of autonomic dysfunction, a growing body of literature has identified OH as a common comorbidity of hypertension. These strategies include countermaneuvers and short-acting vasoactive agents (midodrine, droxidopa).
Background Current pharmacological approaches for the treatment of orthostatic hypotension (OH) may detrimentally affect supine bloodpressure (BP). Pyridostigmine has been proposed as a potential treatment alternative which may improve OH without worsening supine hypertension.
The frequent concurrence of elevated bloodpressure (BP) and type 2 diabetes markedly elevates the risk of cardiovascular disease and mortality. The review introduces a mediation model, delineating the intricate interplay between hypertension and diabetes and their joint contribution to cardiovascular and renal pathologies.
Background Hypertension has now developed into a major public health problem worldwide. Acupuncture, a core technique in the non-pharmacological treatment of Chinese medicine, plays an important role in the treatment of elevated bloodpressure. to −6.06, P < 0.01) and DBP (MD: −7.04, 95% CI: −10.83
A new peer-reviewed study published in the Journal of the American Heart Association , JAHA, found that Hello Heart’s digital heart health program was associated with reductions in bloodpressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight. of their body weight. Of 102,475 participants, 49.1%
Bakris , an internationally recognized and influential nephrologist and hypertension expert, who passed away on June 15, 2024, at the age of 72. Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression.
Background:Primary pulmonary arterial hypertension (PAH) is a disease affecting young subjects. hypoxic animals developed PAH with peak RV systolic pressures (RVSP) being significantly higher than normoxic WT and hypoxic WT and hypoxic KO mice. Pharmacological inhibition of GPR39 may open new frontiers in the treatment of PAH.
However, the renal effects of different doses of liraglutide in an essential hypertension model have not yet been investigated. LH augmented collagen and early markers of kidney injury (blood urea nitrogen-BUN, BUN/Cr). Both doses’ effects were independent of bloodpressure and glycemic control. mg/kg, LL) and high (0.6
3) Examine Your BloodPressure Checking your bloodpressure regularly, whether from your physician or indeed the cuff at the drugstore, can keep hypertension from sneaking up on you. Some need to get advice from their physician about how they can reduce or control hypertension.
The influence of IL-17 inhibition on bloodpressure in autoimmune disease patients remains inconclusive. Our objective is to examine the risk of hypertension in patients with autoimmune diseases undergoing IL-17 inhibition therapies via meta-analysis of randomized, placebo-controlled trials (RCTs).
The aim was to explore the effect of irbesartan combining with emodin on myocardial remodeling in goldblatt (2K-1C) hypertensive rats. Results: Compared with 2K1C group, the 2K1C/Irbesartan group and 2K-1C/Emodin plus Irbesartan group had significantly lower systolic bloodpressure and local Angiotensin II(P<0.05).
Hypertension, Ahead of Print. This steroid hormone regulates salt reabsorption in the kidney and bloodpressure. Pharmacological inhibition of T-type channels alone will likely not significantly impact aldosterone production in the long term.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 Atrial Fibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
Bloodpressure and lipid profile should be controlled appropriately to guideline targets. Overall, comprehensive assessment and pharmacological modification of risk factors are central to stroke prevention. In patients with diabetes, good glycaemic control can reduce stroke risk.
It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high bloodpressure. Food and Drug Administration (FDA) in 2021 as a once-weekly injection for chronic weight management in adults with obesity and at least one weight-related condition such as type 2 diabetes or hypertension.
Dilated pupils and hypertension are a strong clue to sympathetic overload, but don't forget anticholinergic syndromes, including tricyclics! I have treated several patients with severe hypertension and tachycardia due to cocaine and/or methamphetamine with a combination of esmolol + nitroprusside or phentolamine.
It was edited by Smith CASE : A 52-year-old male with a past medical history of hypertension and COPD summoned EMS with complaints of chest pain, weakness and nausea. The initial bloodpressure was 80/palp with a heart rate of 104, respirations 20, oxygen saturations of 94% and a finger stick blood glucose of 268.
There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] So, if a patient is concerned about their weight or bloodpressure, treatment needs to be individualized accordingly. [26]
4.40, P=0.055; or HF plus hypertension:1.69, 0.53–5.35, 35.46, P<0.001), hypertension (4.30, 1.98–9.37, 9.37, P<0.001), or diabetes plus hypertension (5.44, 1.92–15.43, When co-therapy is unavoidable, early monitoring of renal function, blood volume and bloodpressure is excessively crucial. 15.43, P=0.001).
Results revealed that women are twice as likely to exhibit myocardial ischemia in response to mental stress compared to traditional stressors like exercise or pharmacologic stress. Combining behavioral and pharmacological treatment is most effective. Moreover, women under 50 years old are four times more likely to experience MSIMI.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content